Comparison Between Oral Contraceptive Pills & Calcium Supplements in

Status Completed

Clinical Trial Summary

Premenstrual syndrome represents a group of problems affecting most of women in reproductive age. These problems include emotional and physical symptoms. In this study the efficacy of oral contraceptive pills and calcium supplements in relieving these symptoms will be assessed .

Clinical Trial Description

Premenstrual syndrome (PMS) is deﬁned as the recurrence of psychological and physical symptoms in the luteal phase, which remit in the follicular phase of the menstrual cycle [1].PMS will be prospectively diagnosed using the Royal college of Obstetricians and Gynecologists (RCOG) recommended daily record of severity of problems (DRSP) . Women will be asked to fill the diary for 2 months, only women with 30% increase in the DRSP score in the week before menses in both months will be diagnosed as having PMS.

Women with PMS will be invited to participate in the study.The invitation will include a clear full explanation of the study and patients will provide written consents. All patients consenting to participate will be included in the trial.

Yasmin, Calver and Placebo will be enclosed in sequentially numbered similar bottles which will be numbered using a computer generated random table. Women will be asked to choose a sealed envelope, each envelope will contain the number allocated to the jar and special instructions on how to use the medication. Yasmin will be taken once daily for 21 days starting from the 2nd day of menstruation, Calver and placebo will be taken continuously. Neither the patients nor the physician will be aware of the drug used. Patients will be categorized in 3 groups: group1 who will receive Yasmin cyclically for 3 months (Yasmin, schering, cairo, Egypt) and daily oral placebo, group 2 who will receive Calver continuously for 3 months (Calver, Marcryl/Vertex, Cairo Egypt) and oral placebo for 21 days, group 3 who will receive a daily placebo and a placebo similar to COC for 21 days and will act as a control group. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02089620
Study type	Interventional
Source	Beni-Suef University
Contact
Status	Completed
Phase	Phase 3
Start date	May 2014
Completion date	June 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02481973` - The Effect of Individualised Homoeopathic Treatment Using the Grant Bentley Method in Premenstrual Syndrome	Phase 2
Completed	`NCT00195559` - Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder	Phase 3
Completed	`NCT00048854` - Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder	Phase 1/Phase 2
Completed	`NCT00965562` - Comparison of Fluoxetine, Calcium and Placebo for the Treatment of Moderate to Severe Premenstrual Syndrome (PMS)	N/A
Completed	`NCT05349344` - Effect of Aerobic Exercise on Premenstrual Syndrome Symptoms (PMS).	N/A
Recruiting	`NCT06146673` - A Multidimensional Study of Premenstrual Syndrome and Body Image
Recruiting	`NCT05836454` - The Soft Tissue Mobilization Techniques on PMS	N/A
Completed	`NCT05499000` - The Effect of Emotional Freedom Technique on Premenstrual Syndrome	N/A
Recruiting	`NCT06144073` - The Effect of Mandala Art Therapy in Coping With Premenstrual Syndrome	N/A
Recruiting	`NCT06105567` - The Effect of Education Given According to the Health Promotion Model on Premenstrual Symptoms, Emotional Eating Behavior and Perceived Stress	N/A
Completed	`NCT03298607` - The Impact of Serelys PMS on Symptoms of PMS	Phase 3
Recruiting	`NCT06176313` - Effects of Training Given to Cope With Premenstrual Syndrome and Mandala Activity on Premenstrual Symptoms	N/A
Recruiting	`NCT02562053` - Does Adding Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome?	Phase 3
Completed	`NCT00229346` - Fibromyalgia and Psychiatric Symptoms Among PMS and PMDD Patients	N/A
Completed	`NCT00516113` - A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual Dysphoria	Phase 4
Completed	`NCT04901598` - Physical Activity Level, Aerobic Capacity and Dietary Habits Among a Cohort of Females With Premenstrual Syndrome
Completed	`NCT05692479` - Premenstrual Syndrome and Physical Activity Self-Worth
Recruiting	`NCT05665972` - Effects of Mandala Coloring on Premenstrual Syndrome	N/A
Not yet recruiting	`NCT06052722` - The Relationship of Premenstrual Syndrome and Primary Dysmenorrhea With Severity of Temporomandibular Disorders	N/A
Completed	`NCT05556252` - The Effect of Hydrogen-rich Water on Premenstrual Symptoms and Quality of Life	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Comparison Between Oral Contraceptive Pills and Calcium Supplements in Treatment of Premenstrual Syndrome — PMS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms